Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Prometheus Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 144 | 1 | 221 | +78 |
| Shares | 32.9M | 29.6K | 38.1M | +5.23M (+15.9%) |
| Value | $1.94B | $1.75M | $4.19B | +$2.25B (+116.2%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (94)
Institutions that held Prometheus Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (16)
Institutions that held Prometheus Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Balyasny Asset Management LLC | 262,702 | $15.5M |
| Jacobs Levy Equity Management, Inc | 133,831 | $7.90M |
| Tri Locum Partners LP | 123,599 | $7.29M |
| VR Adviser, LLC | 121,663 | $7.18M |
| Empowered Funds, LLC | 39,890 | $2.35M |
| Putnam Investments LLC | 36,713 | $2.17M |
| Calamos Advisors LLC | 25,612 | $1.51M |
| J. Goldman & Co LP | 19,190 | $1.13M |
| Raymond James Financial Services Advisors, Inc. | 13,036 | $769.0K |
| Chartwell Investment Partners, LLC | 9,408 | $555.0K |
| Winton Group Ltd | 7,311 | $431.0K |
| Virtu Financial LLC | 4,956 | $292.0K |
| Aigen Investment Management, LP | 4,206 | $248.0K |
| PEAK6 Investments LLC | 4,000 | $236.0K |
| Amundi | 3,460 | $206.0K |
| Walleye Capital LLC | 1,627 | $96.0K |
Not filed for Q4 2022 yet (1)
Institutions that held Prometheus Biosciences, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Dowling & Yahnke LLC | 29,613 | $1.75M |